General Information of Drug Off-Target (DOT) (ID: OTRKRW50)

DOT Name Cystatin-SA (CST2)
Synonyms Cystatin-2; Cystatin-S5
Gene Name CST2
Related Disease
Bacterial vaginosis ( )
Diabetic kidney disease ( )
Head-neck squamous cell carcinoma ( )
Myocardial infarction ( )
Neoplasm ( )
Non-insulin dependent diabetes ( )
Oral lichen planus ( )
Ovarian cancer ( )
Periodontal disease ( )
Asthma ( )
UniProt ID
CYTT_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF00031
Sequence
MAWPLCTLLLLLATQAVALAWSPQEEDRIIEGGIYDADLNDERVQRALHFVISEYNKATE
DEYYRRLLRVLRAREQIVGGVNYFFDIEVGRTICTKSQPNLDTCAFHEQPELQKKQLCSF
QIYEVPWEDRMSLVNSRCQEA
Function Thiol protease inhibitor.
Tissue Specificity Expressed in submandibular and sublingual saliva but not in parotid saliva (at protein level). Expressed in submandibular gland and parotid gland.
KEGG Pathway
Salivary secretion (hsa04970 )

Molecular Interaction Atlas (MIA) of This DOT

10 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Bacterial vaginosis DISK2MZ2 Strong Biomarker [1]
Diabetic kidney disease DISJMWEY Strong Altered Expression [2]
Head-neck squamous cell carcinoma DISF7P24 Strong Biomarker [3]
Myocardial infarction DIS655KI Strong Genetic Variation [4]
Neoplasm DISZKGEW Strong Altered Expression [5]
Non-insulin dependent diabetes DISK1O5Z Strong Altered Expression [2]
Oral lichen planus DISVEAJA Strong Altered Expression [6]
Ovarian cancer DISZJHAP Strong Altered Expression [5]
Periodontal disease DISJQHVN Strong Biomarker [2]
Asthma DISW9QNS Disputed Altered Expression [7]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
3 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of Cystatin-SA (CST2). [8]
Zoledronate DMIXC7G Approved Zoledronate increases the expression of Cystatin-SA (CST2). [9]
Lucanthone DMZLBUO Approved Lucanthone increases the expression of Cystatin-SA (CST2). [10]
------------------------------------------------------------------------------------
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Cystatin-SA (CST2). [11]
------------------------------------------------------------------------------------

References

1 Factors associated with the composition and diversity of the cervical microbiota of reproductive-age Black South African women: a retrospective cross-sectional study.PeerJ. 2019 Aug 15;7:e7488. doi: 10.7717/peerj.7488. eCollection 2019.
2 Salivary and serum cystatin SA levels in patients with type 2 diabetes mellitus or diabetic nephropathy.Arch Oral Biol. 2019 Aug;104:67-75. doi: 10.1016/j.archoralbio.2019.05.020. Epub 2019 May 22.
3 Cysteine proteinase inhibitor cystatin C in squamous cell carcinoma of the head and neck: relation to prognosis.Br J Cancer. 2004 May 17;90(10):1961-8. doi: 10.1038/sj.bjc.6601830.
4 Association of a polymorphism of BTN2A1 with myocardial infarction in East Asian populations.Atherosclerosis. 2011 Mar;215(1):145-52. doi: 10.1016/j.atherosclerosis.2010.12.005. Epub 2010 Dec 15.
5 Expression of high molecular weight cysteine proteinase inhibitor in ovarian cancer tissues: regulation of cathepsin B expression by placental CPI.Biol Chem. 2003 Jul;384(7):1103-7. doi: 10.1515/BC.2003.123.
6 Putative salivary protein biomarkers for the diagnosis of oral lichen planus: a case-control study.BMC Oral Health. 2018 Mar 13;18(1):42. doi: 10.1186/s12903-018-0504-8.
7 Discriminant analysis followed by unsupervised cluster analysis including exosomal cystatins predict presence of chronic rhinosinusitis, phenotype, and disease severity.Int Forum Allergy Rhinol. 2019 Sep;9(9):1069-1076. doi: 10.1002/alr.22380. Epub 2019 Jul 19.
8 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
9 Interleukin-19 as a translational indicator of renal injury. Arch Toxicol. 2015 Jan;89(1):101-6.
10 Lucanthone is a novel inhibitor of autophagy that induces cathepsin D-mediated apoptosis. J Biol Chem. 2011 Feb 25;286(8):6602-13.
11 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.